Senior insider sale
EVP, Global Research and CSO at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$6.40M
12.92K shares
ALTSHULER DAVID plans to sell 12.92K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $6.40M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/26/2025 | Restricted Stock Vesting Compensation | 1.27K | — |
2/24/2025 | Restricted Stock Vesting Compensation | 848.00 | — |
2/17/2025 | Restricted Stock Vesting Compensation | 490.00 | — |
2/10/2025 | Restricted Stock Vesting Compensation | 621.00 | — |
| Total | 3.23K | ||
Completed
Units to sell
3.23K
Market value
$1.62M
Units to sell
3.23K
Market value
$1.58M
Units to sell
1.27K
Market value
$610.6K
Units to sell
848.00
Market value
$407.8K
Units to sell
1.11K
Market value
$533.3K
Planned — Approximate Date
Units to sell
3.23K
Market value
$1.65M
Units
12.92K
Value
$6.40M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/10/2025 | 3.23K | $1.62M | — | Completed |
3/3/2025 | 3.23K | $1.58M | — | Completed |
2/27/2025 | 1.27K | $610.6K | — | Completed |
2/25/2025 | 848.00 | $407.8K | — | Completed |
2/20/2025 | 1.11K | $533.3K | — | Completed |
| Planned — Approximate Date | ||||
3/13/2025 | 3.23K | $1.65M | NASDAQ | Planned |
| Total | 12.92K | $6.40M | ||